For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Store reconstituted peptides in plain sterile water in the freezer (not the fridge) to prevent bacterial growth, and use within 23 weeks
Symptoms may become severe, including confusion, nerve damage in the arms and legs, difficulty walking, loss of balance and coordination, depression, heart problems, and other complications
FDA reviewers flagged that the compound nominations did not consistently specify which form was being evaluated
When combined with a balanced diet and regular exercise, these injections can support your journey toward a healthier lifestyle
Intriguingly, LL-37 also has anti-inflammatory properties in certain contexts, making it a dual-natured molecule